Apollo Care, LLC recalls SEMAGLUTIDE 2.5mg
- Recalling company
- Apollo Care, LLC
- Product
- SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02
- Reason
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 29, 2026
- Reported
- Aug 19, 2026
- Distribution
- Nationwide within the U.S
- Status
- Ongoing
- Quantity
- 250 vials.
- Lot / codes
- Lot: AC-017271, Exp. 12/12/2026.
- Company location
- Columbia, MO
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0753-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0753-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.